A detailed history of Advisor Group Holdings, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 28,441 shares of CTLT stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,441
Previous 5,626 405.53%
Holding current value
$1.81 Million
Previous $316,000 444.94%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.16 - $60.96 $1.28 Million - $1.39 Million
22,815 Added 405.53%
28,441 $1.72 Million
Q2 2024

Aug 13, 2024

SELL
$53.58 - $57.02 $397,510 - $423,031
-7,419 Reduced 56.87%
5,626 $316,000
Q1 2024

May 10, 2024

SELL
$42.56 - $59.82 $451,689 - $634,869
-10,613 Reduced 44.86%
13,045 $736,000
Q4 2023

Feb 12, 2024

SELL
$32.18 - $46.57 $506,127 - $732,452
-15,728 Reduced 39.93%
23,658 $1.06 Million
Q3 2023

Nov 13, 2023

SELL
$44.2 - $50.2 $540,787 - $614,197
-12,235 Reduced 23.7%
39,386 $1.79 Million
Q2 2023

Aug 10, 2023

BUY
$31.86 - $67.26 $615,567 - $1.3 Million
19,321 Added 59.82%
51,621 $2.24 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $193,483 - $316,199
4,258 Added 15.18%
32,300 $2.12 Million
Q4 2022

Feb 10, 2023

SELL
$41.39 - $81.0 $108,814 - $212,949
-2,629 Reduced 8.57%
28,042 $1.26 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $155,356 - $242,825
-2,147 Reduced 6.54%
30,671 $2.22 Million
Q2 2022

Aug 10, 2022

BUY
$87.2 - $114.05 $192,624 - $251,936
2,209 Added 7.22%
32,818 $3.52 Million
Q1 2022

May 04, 2022

BUY
$94.19 - $124.49 $89,763 - $118,638
953 Added 3.21%
30,609 $3.13 Million
Q3 2021

Nov 05, 2021

BUY
$109.17 - $142.35 $222,379 - $289,966
2,037 Added 7.38%
29,656 $3.92 Million
Q2 2021

Aug 02, 2021

SELL
$100.34 - $115.69 $1.25 Million - $1.44 Million
-12,430 Reduced 31.04%
27,619 $2.99 Million
Q1 2021

May 13, 2021

BUY
$101.51 - $125.27 $933,993 - $1.15 Million
9,201 Added 29.83%
40,049 $4.22 Million
Q4 2020

Feb 10, 2021

BUY
$85.88 - $105.36 $339,311 - $416,277
3,951 Added 14.69%
30,848 $3.21 Million
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $115,729 - $147,167
1,591 Added 6.29%
26,897 $2.3 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $75,247 - $123,855
1,567 Added 6.6%
25,306 $1.86 Million
Q1 2020

May 18, 2020

BUY
$36.95 - $62.95 $877,156 - $1.49 Million
23,739 New
23,739 $1.23 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.